[Clinicoimmunological effects of piracetam and aevit in the course of duodenal ulcer patients' therapy].
Balobanov
V I
VI
Department of Polyclinic Therapy, Izhevsk State Medical Academy.
Vakhrushev
S P
SP
Velikosel'skaia
L M
LM
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000975:Antioxidants / Q000008:administration & dosage / Q000627:therapeutic use*; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D004381:Duodenal Ulcer / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D016145:Endoscopy, Digestive System; D006801:Humans; D007136:Immunoglobulins / Q000097:blood / Q000187:drug effects; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D018696:Neuroprotective Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D010889:Piracetam / Q000008:administration & dosage / Q000627:therapeutic use*; D014801:Vitamin A / Q000008:administration & dosage / Q000627:therapeutic use*; D014810:Vitamin E / Q000008:administration & dosage / Q000627:therapeutic use*
D000975:Antioxidants; D004338:Drug Combinations; D007136:Immunoglobulins; D018696:Neuroprotective Agents; D014801:Vitamin A; D014810:Vitamin E; C048974:vitamin A, vitamin E drug combination; D010889:Piracetam